Keeping Safe and Effective Medications Accessible

Maryann Mazer-Amirshahi^{1

2}, Peggy Ye^{3

4}, Andrew Stolbach⁵

Affiliations

¹ Georgetown University School of Medicine, Washington, DC, USA. Maryannmazer@gmail.com.
² Department of Emergency Medicine, MedStar Washington Hospital Center, Washington, DC, 20010, USA. Maryannmazer@gmail.com.
³ Georgetown University School of Medicine, Washington, DC, USA.
⁴ Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, DC, USA.
⁵ Department of Emergency Medicine, Johns Hopkins University, Baltimore, MD, USA.

Editorial

Maryann Mazer-Amirshahi et al. J Med Toxicol. 2023 Jul.

. 2023 Jul;19(3):244-245.

doi: 10.1007/s13181-023-00949-z. Epub 2023 May 26.

Maryann Mazer-Amirshahi^{1

2}, Peggy Ye^{3

4}, Andrew Stolbach⁵

¹ Georgetown University School of Medicine, Washington, DC, USA. Maryannmazer@gmail.com.
² Department of Emergency Medicine, MedStar Washington Hospital Center, Washington, DC, 20010, USA. Maryannmazer@gmail.com.
³ Georgetown University School of Medicine, Washington, DC, USA.
⁴ Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, DC, USA.
⁵ Department of Emergency Medicine, Johns Hopkins University, Baltimore, MD, USA.

No abstract available

Keywords: Drug approval; Drug safety; Food and Drug Administration; Mifepristone.

Conflict of interest statement

None.

1. U.S. Food and Drug Administration. Medication Review. 2023. https://www.fda.gov/drugs/development-approval-process-drugs. Accessed 20 Apr 2023.
1. U.S. Food and Drug Administration. Code of Federal Regulations Title 21. 2023. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?f.... Accessed 13 May 2023.
1. Center for Reproductive Rights. District Court Ruling. 2023. https://reproductiverights.org/wp-content/uploads/2023/04/TX-district-co.... Accessed 20 Apr 2023.
1. Center for Reproductive Rights. Supreme Court of the United States. 598 U.S. 2023. https://reproductiverights.org/wp-content/uploads/2023/04/Supreme-court-.... Accessed 20 Apr 2023.
1. Product information. MIFEPREX(R) oral tablets, mifepristone oral tablets. New York, NY: Danco Laboratories (per FDA); 2016. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020687s020lbl.pdf. Accessed 23 May 2023.